Nephrotic syndrome induced by cetuximab in a patient with metastatic colorectal cancer.

Mustafa Korkmaz Engin Hendem Melek Karakurt EryılmazAykut DemirkıranMustafa Karaağaç Mustafa Yıldırım

Published in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2022)

Therefore, drugs targeting epidermal growth factor receptor (EGFR) monoclonal antibody were thought to trigger nephrotic syndrome by causing glomerular damage. As a result, physicians using EGFR monoclonal inhibitors should be very careful about renal functions and proteinuria in patients.

Keyphrases

epidermal growth factor receptor
metastatic colorectal cancer
tyrosine kinase
monoclonal antibody
advanced non small cell lung cancer
small cell lung cancer
primary care
oxidative stress
prognostic factors
cancer therapy
patient reported outcomes
drug delivery
patient reported
drug induced